Biotechnology | COVID-19 | HIV | Life Science News | Vaccine
WHO added LC16m8 mpox vaccine to Emergency Use Listing
On Nov. 19, 2024, the World Health Organization (WHO) announced it had granted Emergency Use Listing (EUL) to Japan-based…
California Reports First Known U.S. Case of Emerging Mpox Strain
On Nov. 16, 2024, the California Department of Public Health (CDPH) announced it had identified through laboratory testing…
Vaccine doses allocated to African countries hardest hit by mpox surge
On Nov. 9, 2024, the World Health Organization announced that three additional countries had confirmed travel-related cases of…
Vaccine doses allocated to African countries hardest hit by mpox surge
On Nov. 6, 2024, the World Health Organization announced that the Access and Allocation Mechanism (AAM) for mpox…
WHO and partners activate Global Health Emergency Corps for the first time in response to mpox outbreak
On Oct. 29, 2024, the World Health Organization (WHO) announced that it had, in collaboration with Member States,…
Mpox vaccine is safe and generates a robust antibody response in adolescents
On Oct. 16, 2024, a National Institutes of Health (NIH)-funded clinical trial of an mpox vaccine in adolescents…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Influenza | Life Science News | Therapeutics | Vaccine
New risks raise pandemic threat on a global scale
On Oct. 14, 2024, the Global Preparedness Monitoring Board (GPMB) released a report that outlined 15 key drivers…
U.S. officials reported Cluster of drug-resistant mpox identified in five states
On Oct. 10, 2024, health officials from the U.S. Centers for Disease Control and Prevention announced they had…
WHO approved first mpox diagnostic test for emergency use, boosting global access
On Oct. 3, 2024, the World Health Organization (WHO) announced it had listed the first mpox in vitro…
White House announced 1 million vaccine doses for Africa’s mpox response
On Sept. 24, 2024, U.S. President Joe Biden announced the donation of 1 million mpox vaccine doses and…
EMA recommended extending indication of mpox vaccine to adolescents
On Sept. 19, 2024, the European Medical Agency (EMA) announced it had recommended extending the indication of the…
Biotechnology | Disease | Life Science News | NIH | Non-Profit Research | Pharmaceutical | Therapeutics | Vaccine
Emergent BioSolutions’ ACAM2000® Received U.S. FDA Approval for Mpox Indication
On Aug. 29, 2024, Emergent BioSolutions announced that the U.S. Food and Drug Administration (FDA) had approved the supplemental Biologics…
Biotechnology | Disease | Life Science News | Therapeutics | Vaccine | WHO
Global strategic preparedness and response plan launched by WHO to contain mpox outbreak
On Aug. 26, 2024, the World Health Organization (WHO) launched a global Strategic Preparedness and Response Plan to…
Biotechnology | Diagnostics | Disease | Life Science News | Non-Profit Research | Therapeutics | Vaccine
ECDC recommended enhancing preparedness as more imported cases of clade I mpox highly likely
ON Aug. 16, 2024, the European Centre for Disease Prevention and Control (ECDC) reported that it is highly…
Biotechnology | Disease | Life Science News | Medicine | Vaccine | WHO
WHO declared mpox outbreak a public health emergency of international concern
On Aug. 14, 2024, The World Health Organization declared that the upsurge of mpox in the Democratic Republic…
NIH scientists develop mouse model to study Mpox virulence
On Feb. 14, 2023, scientists from the National Institute of Allergy and Infectious Diseases announced they had developed…
Biotechnology | CDC | Diagnostics | Genomics | Infectious Disease | Life Science History | Therapeutics | Vaccine
The CDC responded to U.S. outbreak of mpox, first human Mpox outside of Africa
On Jul. 8, 2003, the U.S. Centers for Disease Control and Prevention (CDC) responded to U.S. outbreak of…